Screener
Rhythm Pharmaceuticals, Inc. RYTM Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s invested capital?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported invested capital of $173.08M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s invested capital increased by 554.6% year-over-year, from $26.44M to $173.08M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s invested capital has grown at a 22.5% compound annual growth rate (CAGR), from $71.31M to $196.94M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Rhythm Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude